Yüklüyor......
Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen
Superantigens activate T-cells by linking the T-cell receptor to MHC class II on antigen-presenting cells, and novel reactivity can be introduced by fusing the superantigen to a targeting molecule. Thus, an antibody-targeted superantigen, which activates T cells to destroy tumour cells, might be use...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2001
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2363924/ https://ncbi.nlm.nih.gov/pubmed/11437414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.1891 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|